Zusammenfassung
Die gastroösophageale Refluxerkrankung (GERD) stellt eines der häufigsten gastroenterologischen Krankheitsbilder dar und zeigt einen deutlichen Anstieg der Prävalenz in den letzten Jahren. In der Krankheitsausprägung und -entstehung existieren geschlechtsspezifische Unterschiede, die differenziert betrachtet werden sollten. Männer haben eine stärkere Ausbildung der GERD in Hinblick auf den Grad der Entzündung und den Säurereflux. Wahrscheinlich ist aus diesem Grund das Risiko für die Entwicklung eines Barrett-Ösophagus bei Männern etwa 2‑ bis 3-fach und für ein ösophageales Adenokarzinom sogar 3‑ bis 6-mal höher als bei Frauen. Dies unterstreicht die Notwendigkeit, geschlechtsspezifische Unterschiede der GERD besser zu verstehen, um Diagnostik, Therapie und Prävention zu optimieren.
Abstract
Gastroesophageal reflux disease (GERD) represents one of the most common gastrointestinal diseases and has shown a significant increase in prevalence in recent years. There are gender-specific differences in GERD both for disease characteristics and development of the disease. Men suffer from more severe reflux with a higher grade of inflammation and acid reflux. Most probably, this seems to be the underlying reason why men have a higher risk for the development of disease-associated complications like Barrett’s esophagus (approximately 2- to 3‑fold) and esophageal adenocarcinoma (3 to 6 times higher). This underlines the importance of better understanding the gender-specific differences of GERD in order to optimize patient care including prevention, diagnosis and treatment.
Literatur
Alvarez-Sánchez A, Rey E, Achem SR, Dı́az-Rubio M (1999) Does progesterone fluctuation across the menstrual cycle predispose to gastroesophageal reflux? Am J Gastroenterol 94:1468–1471. https://doi.org/10.1016/S0002-9270(99)00184-7
Asanuma K, Iijima K, Shimosegawa T (2016) Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol 22:1800. https://doi.org/10.3748/wjg.v22.i5.1800
Ashcroft GS, Dodsworth J, van Boxtel E et al (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3:1209–1215
van Blankenstein M, Looman CW, Johnston BJ, Caygill CP (2005) Age and sex distribution of the prevalence of Barrett’s esophagus found in a primary referral endoscopy center. Am J Gastroenterol 100:568–576. https://doi.org/10.1111/j.1572-0241.2005.40187.x
Bosetti C, Levi F, Ferlay J et al (2008) Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer 122:1118–1129. https://doi.org/10.1002/ijc.23232
Cappell MS (1998) The safety and efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am 27:37–71
Cook MB, Wild CP, Forman D (2005) A systematic review and Meta-analysis of the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive reflux disease. Epidemiol Rev 162:1050–1061. https://doi.org/10.1093/aje/kwi325
Corley DA (2007) Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut 56:1493–1494. https://doi.org/10.1136/gut.2007.124255
Corley DA, Kubo A, Levin TR et al (2007) Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Baillieres Clin Gastroenterol 133:34–41. https://doi.org/10.1053/j.gastro.2007.04.046
Derakhshan MH, Liptrot S, Paul J et al (2009) Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut 58:16–23. https://doi.org/10.1136/gut.2008.161331
El-Serag HB, Hashmi A, Garcia J et al (2014) Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett’s oesophagus: a case-control study. Gut 63(220):2–229. https://doi.org/10.1136/gutjnl-2012-304189
El-Serag HB, Sweet S, Winchester CC, Dent J (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63:871–880. https://doi.org/10.1136/gutjnl-2012-304269
Endlicher E, Gelbmann C, Messmann H (2009) Refluxerkrankung und Barrett-Ösophagus – Gibt es geschlechtsspezifische Unterschiede? Z Gastroenterol 47:1065–1068. https://doi.org/10.1055/s-0028-1109331
Eusebi LH, Ratnakumaran R, Yuan Y et al (2018) Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 67:430–440. https://doi.org/10.1136/gutjnl-2016-313589
Falk GW, Thota PN, Richter JE et al (2005) Barrett’s esophagus in women: demographic features and progression to high-grade dysplasia and cancer. Clin Gastroenterol Hepatol 3:1089–1094
Fass R, Ofman JJ (2002) Gastroesophageal reflux disease-should we adopt a new conceptual framework? Am J Gastroenterol 97:1901–1909. https://doi.org/10.1111/j.1572-0241.2002.05912.x
Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults. JAMA 307(491):1999–2010. https://doi.org/10.1001/jama.2012.39
Ford AC, Forman D, Reynolds PD et al (2005) Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett’s esophagus. Epidemiol Rev 162:454–460. https://doi.org/10.1093/aje/kwi218
Ford ES, Li C, Zhao G, Tsai J (2011) Trends in obesity and abdominal obesity among adults in the United States from 1999–2008. Int J Obes Relat Metab Disord 35:736–743. https://doi.org/10.1038/ijo.2010.186
Green J, Czanner G, Reeves G et al (2012) Menopausal hormone therapy and risk of gastrointestinal cancer: Nested case-control study within a prospective cohort, and meta-analysis. Int J Cancer 130:2387–2396. https://doi.org/10.1002/ijc.26236
Grishina I, Fenton A, Sankaran-Walters S (2014) Gender differences, aging and hormonal status in mucosal injury and repair. Aging Dis 5:160–169. https://doi.org/10.14336/AD.2014.0500160
Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143:199–211
Hvid-Jensen F, Pedersen L, Drewes AM et al (2011) Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 365:1375–1383. https://doi.org/10.1056/NEJMoa1103042
Jaspersen D, Kulig M, Labenz J et al (2003) Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 17:1515–1520
Kandulski A, Moleda L, Müller-Schilling M (2018) Diagnostic investigations of gastroesophageal reflux disease: who and when to refer and for what test? Visc Med 34:97–100. https://doi.org/10.1159/000488184
Katz PO, Gerson LB, Vela MF (2013) Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 108:308–328. https://doi.org/10.1038/ajg.2012.444
Koelz HR, Blum AL, Modlin IM (2003) Costs of gerd: facts and fiction. Baillieres Clin Gastroenterol 125:981–982
Koop H, Fuchs K, Labenz J et al (2014) S2k-Leitlinie: Gastroösophageale Refluxkrankkheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 52:1299–1346. https://doi.org/10.1055/s-0034-1385202
Kulig M, Leodolter A, Vieth M et al (2003) Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease—an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 18:767–776
Lagergren J, Nyrén O (1998) Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 7:913–915
do Rosário Dias de Oliveira Latorre M, Medeiros da Silva A, Chinzon D et al (2014) Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group. World J Gastroenterol 20:17388. https://doi.org/10.3748/wjg.v20.i46.17388
Lepage C, Rachet B, Jooste V et al (2008) Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 103:2694–2699. https://doi.org/10.1111/j.1572-0241.2008.02191.x
Lin M, Gerson LB, Lascar R et al (2004) Features of gastroesophageal reflux disease in women. Am J Gastroenterol 99:1442–1447. https://doi.org/10.1111/j.1572-0241.2004.04147.x
Macfie AG, Magides AD, Richmond MN, Reilly CS (1991) Gastric emptying in pregnancy. Br J Anaesth 67:54–57
Malfertheiner S, Seelbach-Göbel B (2015) Die gastroösophageale Refluxkrankheit in der Schwangerschaft. Frauenheilkd Up2date 9:257–273. https://doi.org/10.1055/s-0033-1358162
Malfertheiner SF, Malfertheiner MV, Kropf S et al (2012) A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy. BMC Gastroenterol 12:131. https://doi.org/10.1186/1471-230X-12-131
Massl R, van Blankenstein M, Jeurnink S et al (2014) Visceral adipose tissue: the link with esophageal adenocarcinoma. Scand J Gastroenterol 49:449–457. https://doi.org/10.3109/00365521.2013.873818
Menon S, Jayasena H, Nightingale P, Trudgill NJ (2011) Influence of age and sex on endoscopic findings of gastrooesophageal reflux disease: an endoscopy database study. Eur J Gastroenterol Hepatol 23:389–395. https://doi.org/10.1097/MEG.0b013e328345d429
Menon S, Nightingale P, Trudgill N (2014) Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer? United European Gastroenterol J 2:374–382. https://doi.org/10.1177/2050640614543736
Nasseri-Moghaddam S, Mofid A, Ghotbi M‑H et al (2008) Epidemiological study of gastro-oesophageal reflux disease: reflux in spouse as a risk factor. Aliment Pharmacol Ther 28:144–153. https://doi.org/10.1111/j.1365-2036.2008.03708.x
Nguyen P, Lee SD, Castell DO (1995) Evidence of gender differences in esophageal pain threshold. Am J Gastroenterol 90:901–905
Nilsson M, Johnsen R, Ye W et al (2003) Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290:66. https://doi.org/10.1001/jama.290.1.66
Peery AF, Dellon ES, Lund J et al (2012) Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 143:1179–1187.e3. https://doi.org/10.1053/j.gastro.2012.08.002
Pohl H, Wrobel K, Bojarski C et al (2013) Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol 108:200–207. https://doi.org/10.1038/ajg.2012.387
Rey E, Moreno-Elola-Olaso C, Artalejo FR et al (2006) Association between weight gain and symptoms of gastroesophageal reflux in the general population. Am J Gastroenterol 101:229–233. https://doi.org/10.1111/j.1572-0241.2006.00412.x
Richter JE (2005) Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther 22:749–757. https://doi.org/10.1111/j.1365-2036.2005.02654.x
Richter JE, Rubenstein JH (2018) Presentation and Epidemiology of Gastroesophageal Reflux Disease. Baillieres Clin Gastroenterol 154:267–276. https://doi.org/10.1053/j.gastro.2017.07.045
Royston C, Bardhan KD (2017) Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum. Eur J Gastroenterol Hepatol 29:634–639. https://doi.org/10.1097/MEG.0000000000000845
Sandhu DS, Fass R (2018) Current trends in the management of Gastroesophageal Reflux Disease. Gut Liver 12:7–16. https://doi.org/10.5009/gnl16615
Savas N (2014) Gastrointestinal endoscopy in pregnancy. World J Gastroenterol 20:15241–15252. https://doi.org/10.3748/wjg.v20.i41.15241
Shaheen NJ, Hansen RA, Morgan DR et al (2006) The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 101:2128–2138. https://doi.org/10.1111/j.1572-0241.2006.00723.x
van Soest EM, Dieleman JP, Siersema PD et al (2005) Increasing incidence of Barrett’s oesophagus in the general population. Gut 54:1062–1066. https://doi.org/10.1136/gut.2004.063685
Van Thiel DH, Wald A (1981) Evidence refuting a role for increased abdominal pressure in the pathogenesis of the heartburn associated with pregnancy. Am J Obstet Gynecol 140:420–422
Thrift AP, Whiteman DC (2012) The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 23:3155–3162. https://doi.org/10.1093/annonc/mds181
Vakil N, van Zanten SV, Kahrilas P et al (2006) The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920. https://doi.org/10.1111/j.1572-0241.2006.00630.x
Vega KJ, Langford-Legg T, Palacio C et al (2013) Females without reflux symptoms or gastroesophageal reflux disease have less distal esophageal acid exposure than males without reflux symptoms or gastroesophageal reflux disease. Dis Esophagus 26:246–249. https://doi.org/10.1111/j.1442-2050.2012.01367.x
Voutilainen M (2008) Epidemiological trends in oesophageal cancer in the Nordic countries. Scand J Gastroenterol 43:323–327
Wiklund I (2004) Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 22:108–114. https://doi.org/10.1159/000080308
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Selgrad, M. Müller-Schilling und A. Kandulski geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
M. Müller-Schilling, Regensburg
A. Riphaus, Frankfurt am Main
Rights and permissions
About this article
Cite this article
Selgrad, M., Müller-Schilling, M. & Kandulski, A. Gastroösophageale Refluxerkrankung und geschlechtsspezifische Unterschiede. Gastroenterologe 14, 96–101 (2019). https://doi.org/10.1007/s11377-019-0322-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-019-0322-9